Overview

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma

Status:
Terminated
Trial end date:
2021-02-06
Target enrollment:
Participant gender:
Summary
This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.
Phase:
Phase 2
Details
Lead Sponsor:
Rochester General Hospital
Treatments:
Doxycycline